Billionaire Michael Price’s 5 High-Value, High-Dividend Plays Include Intel Corporation (INTC)

Page 1 of 2

Michael Price, who has a net worth of some $1.3 billion, manages his wealth through MFP Investors, an activist hedge fund that focuses on value investments. Price’s opportunistic value-based approach pursues stocks that trade below their intrinsic values, often including those that represent contrarian plays. Value stocks comprise some 60% of Price’s portfolio. The remainder of his portfolio consists of cash and special-situation investments, such as bankruptcy, arbitrage, buyback, and other investments.

Michael Price

In mid-February, Price’s hedge fund filed its 13F with the SEC, disclosing its fourth-quarter portfolio that includes positions in a number of value stocks, including several stocks paying dividend yields above 2.0%. Here is a glance at five such dividend-paying picks that constitute the fund’s largest positions, starting with the largest.

Intel Corporation (NASDAQ:INTC), the world’s most prominent chipmaker, was the second-largest position in Price’s hedge fund last quarter. The position was valued at $35 million. Intel is an obvious value play, boasting a forward P/E of 11.2x, slightly more than half the forward multiple of its respective industry. The stock is priced at 2.1 times price-to-book, below its industry’s average (2.6x) and the stock’s five-year average (2.4x). Intel Corporation (NASDAQ:INTC) also pays a generous dividend, yielding 4.2% on a payout ratio of 47%. The company has raised dividends at an average CAGR of 13.7% over the past five years.

Intel’s sales have been battered recently due to a prolonged slump in the PC market, and this is a reason why the company’s facilities are operating at less than half their capacity. The outlook in the PC market is still dreary, as PC shipments continue to fall more than expected in the first half of 2013, according to IT research firm IDC.

Still, this year, Intel Corporation (NASDAQ:INTC) expects to grow its overall sales in the low single digits, while analysts project a 2% year-over-year increase. In order to end its overdependence on the PC market, Intel is transitioning toward the fast-growing mobile device market. Recently, speculations emerged about a possible future foundry relationship between Intel Corporation (NASDAQ:INTC) and Apple Inc. (NASDAQ:AAPL).

The McGraw-Hill Companies, Inc. (NYSE:MHP) was the fifth-largest equity position in Price’s portfolio in the fourth quarter. The position was worth nearly $28 million. The company recently sold its underperforming educational publishing segment to Apollo Global Management LLC (NYSE:APO) for $2.5 billion; the deal is expected to close before the end of this month. The succeeding firm to McGraw-Hill, McGraw-Hill Financial, will be a high-growth, high-margin benchmark, content and analytics company in the global capital and commodities markets, according to the company. McGraw-Hill has paid dividends each year since 1937 and has raised dividends for 40 consecutive years.

The new successor company, McGraw-Hill Financial, expects to achieve single-digit growth in revenues and a 15% increase in adjusted diluted EPS in 2013, to a range of between $3.10 and $3.20, which puts its forward P/E at 15.4x forward EPS midpoint. At that multiple, the stock is trading about on par with its rival Moody’s Corporation (NYSE:MCO) but below Thompson Reuters Corporation (USA) (NYSE:TRI)’s forward multiple of 17.7x.

Symetra Financial Corporation (NYSE:SYA) was another value pick in Price’s portfolio last quarter. This was MFP Investors’ sixth largest equity position, valued at $23 million. Symetra Financial provides life and health insurance products in the United States. Warren Buffett’s Berkshire Hathaway-controlled entities are among the largest shareholders in this insurance company.

Symetra pays a dividend yield of 2.3% on a payout ratio of 23%. The company recently raised its quarterly dividend by 14.3%. Last year and especially last quarter, the company showed signs of struggle. Its adjusted operating income per share dived in the fourth quarter by 35% to $0.24, markedly missing analyst expectations.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!